Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KS › Hutchinson › NPI 1922039320
Supplier

Hutchinson Regional Medical Center, INC.

Hutchinson Regional Medical Center, INC. was paid $2.45M by Medicaid between Jan 2018 and Nov 2024, across 78 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.

33Billing provider infoHUTCHINSON REGIONAL MEDICAL CENTER, INC.
HUTCHINSON, KS 67502
33aNPI1922039320assigned 07/05/2006
33bProvider typeInstitutional Pharmacy
28Total paid$2.45M
24GClaims123,388
24DCodes billed78
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service

Paid by month

$0$25K$50K$75K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201820,256$461K
201918,193$363K
202015,099$304K
202117,763$336K
202220,782$380K
202320,297$350K
2024incomplete10,998$254K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 22% 12,764 12,341 $551K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 20% 11,952 11,385 $492K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.2% 4,812 4,550 $177K
80053 Comprehensive metabolic panel 5.9% 15,631 14,653 $143K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 4.8% 1,369 1,301 $117K
96375 Therapeutic injection; each additional sequential IV push 4.7% 3,943 3,646 $115K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.8% 5,391 5,121 $92K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.9% 1,631 1,588 $71K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.8% 16,822 15,747 $68K
96361 Intravenous infusion, hydration; each additional hour 2.7% 3,759 3,506 $66K
70450 Computed tomography, head or brain; without contrast material 2.7% 1,039 987 $66K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.4% 598 579 $58K
66 more codes
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.0% 5,077 $50K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.9% 762 $47K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.8% 863 $44K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1.8% 117 $43K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.4% 368 $33K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.2% 1,372 $30K
84484 1.2% 3,825 $30K
71045 Radiologic examination, chest; single view 1.2% 4,665 $29K
84703 <1% 1,886 $17K
83690 <1% 2,203 $15K
97597 <1% 121 $12K
81001 <1% 3,366 $10K
87086 Culture, bacterial; quantitative colony count, urine <1% 744 $7K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 419 $7K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 116 $6K
G0378 Hospital observation service, per hour <1% 50 $4K
71046 Radiologic examination, chest; 2 views <1% 319 $4K
82805 <1% 346 $4K
83605 <1% 565 $4K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 83 $3K
80048 Basic metabolic panel (calcium, ionized) <1% 417 $3K
85610 <1% 822 $3K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 62 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 243 $2K
83880 <1% 168 $2K
72125 Computed tomography, cervical spine; without contrast material <1% 29 $2K
81003 <1% 1,831 $2K
83735 <1% 324 $2K
87400 <1% 84 $1K
87486 <1% 116 $1K
87581 <1% 116 $1K
80143 <1% 94 $1K
84443 Thyroid stimulating hormone (TSH) <1% 88 $975.76
87634 <1% 13 $856.86
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 62 $843.11
80179 <1% 64 $790.85
87077 <1% 65 $599.19
96376 <1% 21 $588.44
87040 <1% 41 $481.09
85730 <1% 124 $468.32
A0427 Emergency ambulance ride, advanced life support <1% 2,727 $444.24
87081 <1% 57 $419.08
85379 <1% 48 $351.60
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 14 $315.75
80320 <1% 26 $298.85
A0429 Emergency ambulance ride, basic life support <1% 789 $294.39
84145 <1% 12 $241.79
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 403 $239.35
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 12 $196.67
87186 <1% 12 $185.77
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 20 $184.68
J1170 Injection, hydromorphone, up to 4 mg <1% 65 $165.55
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 14 $159.87
85027 <1% 16 $159.57
A0425 Ground mileage, per statute mile <1% 3,997 $108.64
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 207 $68.36
J3010 Injection, fentanyl citrate, 0.1 mg <1% 109 $54.86
36415 Collection of venous blood by venipuncture <1% 2,212 $52.65
84100 <1% 14 $50.76
J2270 Injection, morphine sulfate, up to 10 mg <1% 12 $38.86
A9270 Non-covered item or service <1% 323 $25.29
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 30 $21.04
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 12 $11.85
0202U Oncology (prostate), multianalyte, gene expression profiling 0% 338 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 0% 88 $0.00
82077 0% 69 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANDERSON, BENJAMIN (CEO)
Same official

Other billing entities under ANDERSON, BENJAMIN

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.